Please assess the completion status of the following clinical trial:

Trial Title: Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Idiopathic PD~* On a stable medication regimen for at least one month with leg edema occurring after the start of pramipexole or ropinirole and the absence of other possible reasons for discontinuation of pramipexole or ropinirole treatment (e.g. other adverse effects).~Exclusion Criteria:~* Pregnancy~* Breastfeeding~* Women of child bearing age not using a reliable method of contraception~* Coronary disease, abnormal QT interval on electrocardiogram (EKG)~* Diabetes mellitus~* Hepatic disease~* Alcohol abuse~* Renal disease~* Edema of one leg only~* Presence of other conditions possibly causing leg edema

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).